Virtus LifeSci Profile

29.18
USD 0.38  1.29%
2%
75%

Virtus LifeSci Summary

Virtus LifeSci Biotech Clinical Trls ETF [BBC] is traded in USA and was established 2014-12-16. The fund is classified under Health category within Virtus family. Virtus LifeSci Biotech Clinical Trls ETF currently have 51.98 M in assets under management (AUM). , while the total return for the last 3 years was 5.26%.
Check Virtus LifeSci Probability Of Bankruptcy

Geographic Allocation (%)

Virtus LifeSci Biotech Currency Exposure (%)

 % of ETF 
      Currency 

Top Etf Constituents

Virtus LifeSci Target Price Odds Analysis

Odds Below 29.18HorizonTargetOdds Above 29.18
5.05%30 days 29.18 94.90%
Based on normal probability distribution, the odds of Virtus LifeSci to move above current price in 30 days from now is under 95% (This Virtus LifeSci Biotech Clinical Trls ETF probability density function shows the probability of Virtus LifeSci Etf to fall within a particular range of prices over 30 days) .

Virtus LifeSci Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Niemann Capital Management IncFund Units507.2 K16.6 M
View Virtus LifeSci Diagnostics

Virtus LifeSci Biotech Risk Profiles

Virtus LifeSci Biotech Technical Analysis

Transformation
The output start index for this execution was zero with a total number of output elements of seventeen. Virtus LifeSci Biotech Inverse Tangent Over Price Movement function is an inverse trigonometric method to describe Virtus LifeSci price patterns. View also all equity analysis or get more info about inverse tangent over price movement math transform indicator.

Virtus LifeSci Key Fundamentals

Virtus LifeSci Against Markets

Virtus LifeSci Current Ratings

Virtus LifeSci Biotech Clinical Trls ETF 30 Days Performance Scores

Risk Adjusted
Performance Score (0 to 100)
0 
Chance of
Financial Distress (0 to 100%)
2 
Equity ratings for Virtus LifeSci Biotech Clinical Trls ETF are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
The investment seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Clinical Trials Index. Virtus LifeSci is traded on Archipelago Exchange in USA. more
NameVirtus LifeSci Biotech Clinical Trls ETF
Macroaxis Advice
InstrumentUSA Etf View All
RegionNorth America
Investment IssuerVirtus
ExchangeArchipelago Exchange
Etf FamilyVirtus
Fund CategorySector
Portfolio ConcentrationHealth Care
BenchmarkDOW
Phone888 383 0553
CurrencyUSD - US Dollar
IssuerVirtus
DescriptionVirtus LifeSci Biotech Clinical Trials ETF
Inception Date2014-12-17
BenchmarkLifeSci Biotechnology Clinical Trials Index
Entity TypeRegulated Investment Company
Asset Under Management67.99 Million
Average Trading Valume11,235
Asset TypeEquity
CategorySector
FocusHealth Care
Market ConcentrationDeveloped Markets
RegionNorth America
AdministratorVirtus ETF Solutions LLC
AdvisorVirtus ETF Advisers LLC
CustodianThe Bank of New York Mellon Corporation
DistributorETF Distributors LLC
Portfolio ManagerMatthew B. Brown, Seth Kadushin
Transfer AgentThe Bank of New York Mellon Corporation
Fiscal Year EndOctober 31
ExchangeNYSE Arca, Inc.
Number of Constituents100.0
Market MakerVirtu Financial
Total Expense0.79
Management Fee0.79
Nav Price35.85
Last Bear Mkt0.00%
Two Hundred Day Average33.34
Ytd25.82%
Average Daily Volume In Three Month23.66k
Fifty Two Week Low25.88
Last Bull Mkt0.00%
Average Daily Volume Last 10 Day9.2k
Fifty Two Week High36.25
One Month9.52%
Fifty Day Average33.74
Check also Trending Equities. Please also try Crypto Portfolio Optimizer module to optimize portfolio of digital coins and token across multiple currency and exchanges.
Search macroaxis.com